Buprenorphine misuse, abuse, and diversion: When will we ever learn?

Journal of Addictive Diseases

Volumn 26, Issue 3, 2007, Pages 1-3

  Stimmel, Barry ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; DIAMORPHINE;

AGONIST; DRUG ABUSE PATTERN; DRUG DEPENDENCE; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MISUSE; DRUG MONITORING; EDITORIAL; HAZARD ASSESSMENT; HEROIN DEPENDENCE; HUMAN; PHYSICIAN; POISON CENTER;

BUPRENORPHINE; HUMANS; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, MU; SUBSTANCE-RELATED DISORDERS;

EID: 34548389325     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v26n03_01     Document Type: Editorial

References (15)

1. Sandoval RG, Wang RIH. Tolerance and dependence on pentazocine. N Engl J Med. 1969;280:1391-1392.
2. Bailey WJ. Nonmedical use of pentazocine: Letter to the editor. JAMA. 1979;242:2392.
3. O'Driscoll WG, Lindley, GR. Self administration of tripelennamine by a narcotic addict. N Engl J Med. 1957;257:376.
4. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction: A Treatment Improvement Protocol [TIP 40]. Rockville, MD. 2004.
5. Jasinski DR, Pevnick JS, Griffith JD. Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addictions. Arch Gen Psychiatry. 1978;35:501-516.
6. Brady TM, Salvucci S, Sverdlov LS, Male A. Methadone dosage and retention: An examination of the 60mg/day threshold. J Addict Dis. 2005;24(3):23-47.
7. Obadia Y, Perrin V, Feroni I et al. Injecting misuse of buprenorphine among French drug users. Addiction. 2001;96:267-272.
8. Lavelle TL, Hammersley R, Forsyth A, Bain D. The use of buprenorphine and temazepam by drug injectors. J Addict Dis. 1991;10(3):5-14.
9. How safe are methadone, LAAM, buprenorphine? Addiction Treatment Forum. 2001;10(2):1.
10. Mathias R. New approaches seek to expand naltrexone use in heroin treatment. NIDA Research Findings. 2003;17:6.
11. Weinhold LL, Preston KL, Farre M, Liebson IA, Bigelow GE. Buprenorphine alone and in combination with naloxone in non-dependent humans. Drug Alcohol Depend. 1992;30:263-274.
12. Alho H, Sinclair D, Vuori E, Holopainen A. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 2006;22:533-541.
13. Report of the Committee on the Narcotic Drug Situation in the United States. JAMA. 1920;74:1318.
14. Drug Abuse Warning Network, IMS America. Quarterly Report. July-September 1977.
15. Meier B. Narcotic maker guilty of deceit over marketing. The New York Times. May 11, 2007.